Mammal-specific domain of the prion protein may hold clues to neurodegenerative diseases

FHS
May 23, 2024
3:08 pm

A study from Bochum describes a mammal-specific domain of the prion protein and offers new approaches for research into neurodegenerative diseases.

StemSight and ERS Genomics focus on collaboration

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

January 17, 2024

THELMA project examines impact of algorithmic surveillance on women’s reproductive health

In a context of demographic decline, algorithmic surveillance of reproductive health could be used to covertly control reproductive decisions, increase inequalities and violate women’s rights.

October 22, 2024

Opinion | Half-Truths, Big Risks: The Dangers of an Incomplete Medical History

Bitterman is an orthopedic surgeon. Honesty is the lifeblood of the doctor-patient relationship. Without it, even the most skilled physician is working with one hand

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.